United States Immunosuppressant Drugs Market Report 2017

February 2017 | 116 pages | ID: UB064BA770CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Immunosuppressant Drugs

Revenue, means the sales value of Immunosuppressant Drugs

This report studies sales (consumption) of Immunosuppressant Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Astellas Pharma
• Roche
• Pfizer
• Sanofi
• Allergan
• Bristol-Myers Squibb
• AbbVie
• Veloxis Pharmaceuticals
• GSK

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Calcineurin Inhibitors
• MTOR Inhibitors
• Anti-proliferative Agents
• Steroids
• Antibodies

Split by applications, this report focuses on sales, market share and growth rate of Immunosuppressant Drugs in each application, can be divided into

• Kidney
• Bone Marrow
• Others

Contents

United States Immunosuppressant Drugs Market Report 2017

1 IMMUNOSUPPRESSANT DRUGS OVERVIEW

1.1 Product Overview and Scope of Immunosuppressant Drugs
1.2 Classification of Immunosuppressant Drugs
  1.2.1 Calcineurin Inhibitors
  1.2.2 MTOR Inhibitors
  1.2.3 Anti-proliferative Agents
  1.2.4 Steroids
  1.2.5 Antibodies
1.3 Application of Immunosuppressant Drugs
  1.3.1 Kidney
  1.3.2 Bone Marrow
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Immunosuppressant Drugs (2012-2022)
  1.4.1 United States Immunosuppressant Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES IMMUNOSUPPRESSANT DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Immunosuppressant Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Immunosuppressant Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Immunosuppressant Drugs Average Price by Manufactures (2015 and 2016)
2.4 Immunosuppressant Drugs Market Competitive Situation and Trends
  2.4.1 Immunosuppressant Drugs Market Concentration Rate
  2.4.2 Immunosuppressant Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES IMMUNOSUPPRESSANT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Immunosuppressant Drugs Sales and Market Share by States (2012-2017)
3.2 United States Immunosuppressant Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Immunosuppressant Drugs Price by States (2012-2017)

4 UNITED STATES IMMUNOSUPPRESSANT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Immunosuppressant Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Immunosuppressant Drugs Price by Type (2012-2017)
4.4 United States Immunosuppressant Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES IMMUNOSUPPRESSANT DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Immunosuppressant Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Immunosuppressant Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNOSUPPRESSANT DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.1.2.1 Calcineurin Inhibitors
    6.1.2.2 MTOR Inhibitors
  6.1.3 Novartis Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Astellas Pharma
  6.2.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.2.2.1 Calcineurin Inhibitors
    6.2.2.2 MTOR Inhibitors
  6.2.3 Astellas Pharma Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.3.2.1 Calcineurin Inhibitors
    6.3.2.2 MTOR Inhibitors
  6.3.3 Roche Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.4.2.1 Calcineurin Inhibitors
    6.4.2.2 MTOR Inhibitors
  6.4.3 Pfizer Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.5.2.1 Calcineurin Inhibitors
    6.5.2.2 MTOR Inhibitors
  6.5.3 Sanofi Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Allergan
  6.6.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.6.2.1 Calcineurin Inhibitors
    6.6.2.2 MTOR Inhibitors
  6.6.3 Allergan Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.7.2.1 Calcineurin Inhibitors
    6.7.2.2 MTOR Inhibitors
  6.7.3 Bristol-Myers Squibb Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AbbVie
  6.8.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.8.2.1 Calcineurin Inhibitors
    6.8.2.2 MTOR Inhibitors
  6.8.3 AbbVie Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Veloxis Pharmaceuticals
  6.9.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.9.2.1 Calcineurin Inhibitors
    6.9.2.2 MTOR Inhibitors
  6.9.3 Veloxis Pharmaceuticals Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GSK
  6.10.2 Immunosuppressant Drugs Product Type, Application and Specification
    6.10.2.1 Calcineurin Inhibitors
    6.10.2.2 MTOR Inhibitors
  6.10.3 GSK Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 IMMUNOSUPPRESSANT DRUGS MANUFACTURING COST ANALYSIS

7.1 Immunosuppressant Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunosuppressant Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immunosuppressant Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunosuppressant Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNOSUPPRESSANT DRUGS MARKET FORECAST (2017-2022)

11.1 United States Immunosuppressant Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Immunosuppressant Drugs Sales Forecast by Type (2017-2022)
11.3 United States Immunosuppressant Drugs Sales Forecast by Application (2017-2022)
11.4 Immunosuppressant Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Immunosuppressant Drugs
Table Classification of Immunosuppressant Drugs
Figure United States Sales Market Share of Immunosuppressant Drugs by Type in 2015
Figure Calcineurin Inhibitors Picture
Figure MTOR Inhibitors Picture
Figure Anti-proliferative Agents Picture
Figure Steroids Picture
Figure Antibodies Picture
Table Application of Immunosuppressant Drugs
Figure United States Sales Market Share of Immunosuppressant Drugs by Application in 2015
Figure Kidney Examples
Figure Bone Marrow Examples
Figure Others Examples
Figure United States Immunosuppressant Drugs Sales and Growth Rate (2012-2022)
Figure United States Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Table United States Immunosuppressant Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Immunosuppressant Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Immunosuppressant Drugs Sales Share by Manufacturers
Figure 2016 Immunosuppressant Drugs Sales Share by Manufacturers
Table United States Immunosuppressant Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Immunosuppressant Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Immunosuppressant Drugs Revenue Share by Manufacturers
Table 2016 United States Immunosuppressant Drugs Revenue Share by Manufacturers
Table United States Market Immunosuppressant Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Immunosuppressant Drugs Average Price of Key Manufacturers in 2015
Figure Immunosuppressant Drugs Market Share of Top 3 Manufacturers
Figure Immunosuppressant Drugs Market Share of Top 5 Manufacturers
Table United States Immunosuppressant Drugs Sales by States (2012-2017)
Table United States Immunosuppressant Drugs Sales Share by States (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by States in 2015
Table United States Immunosuppressant Drugs Revenue and Market Share by States (2012-2017)
Table United States Immunosuppressant Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Immunosuppressant Drugs by States (2012-2017)
Table United States Immunosuppressant Drugs Price by States (2012-2017)
Table United States Immunosuppressant Drugs Sales by Type (2012-2017)
Table United States Immunosuppressant Drugs Sales Share by Type (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by Type in 2015
Table United States Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)
Table United States Immunosuppressant Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Immunosuppressant Drugs by Type (2012-2017)
Table United States Immunosuppressant Drugs Price by Type (2012-2017)
Figure United States Immunosuppressant Drugs Sales Growth Rate by Type (2012-2017)
Table United States Immunosuppressant Drugs Sales by Application (2012-2017)
Table United States Immunosuppressant Drugs Sales Market Share by Application (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by Application in 2015
Table United States Immunosuppressant Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Immunosuppressant Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Immunosuppressant Drugs Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Veloxis Pharmaceuticals Basic Information List
Table Veloxis Pharmaceuticals Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Veloxis Pharmaceuticals Immunosuppressant Drugs Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunosuppressant Drugs
Figure Manufacturing Process Analysis of Immunosuppressant Drugs
Figure Immunosuppressant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immunosuppressant Drugs Major Manufacturers in 2015
Table Major Buyers of Immunosuppressant Drugs
Table Distributors/Traders List
Figure United States Immunosuppressant Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Immunosuppressant Drugs Production Forecast by Type (2017-2022)
Table United States Immunosuppressant Drugs Consumption Forecast by Application (2017-2022)
Table United States Immunosuppressant Drugs Sales Forecast by States (2017-2022)
Table United States Immunosuppressant Drugs Sales Share Forecast by States (2017-2022)